Skip to content

The effect of immediate nasal catheter oxygenation on the incidence of hypoxemia in patients with postoperative sedation after transfer to post-anesthesia care unit ( PACU ) : A prospective randomized controlled study

The effect of immediate nasal catheter oxygenation on the incidence of hypoxemia in patients with postoperative sedation after transfer to post-anesthesia care unit ( PACU ) : A prospective randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128712
Enrollment
Unknown
Registered
2026-07-24
Start date
2026-07-24
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperpostoperative hypoxemiaative hypoxemia

Interventions

Control group:Normal removal of airway management device after connecting the nasal oxygen catheter oxygen therapy.
Experimental group:After being transferred to PACU, nasal oxygen catheter oxygen therapy was immediately connected.

Sponsors

Tongji Hospital of Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old; 2. ASA classification: I-III; 3. Patients undergoing surgery or procedures under general anesthesia will be transferred to the recovery room after the operation; 4. Voluntary participants in the study and have signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Preoperative presence of bradycardia (heart rate < 50 beats per minute), hypotension (systolic blood pressure < 80 mmHg), or hypoxemia. 2. Need for long-term or intermittent oxygen inhalation due to existing diseases. 3. Concurrent diseases that cannot tolerate a decrease in arterial oxygen saturation or fluctuations in arterial carbon dioxide partial pressure (PaCO2), such as severe cardiovascular and cerebrovascular diseases, intracranial hypertension, or severe pulmonary diseases. 4. Coagulation dysfunction or a tendency to nosebleeds. 5. Patients with nasotracheal intubation. 6. Have participated in other intervention-based clinical studies in the past 3 months. 7. Other conditions judged by the researcher as not suitable for inclusion. 8. Patients or their families refuse to participate in this trial or refuse to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Postoperative hypoxemia;

Secondary

MeasureTime frame
Total length of stay and total cost of hospitalization;Adverse reactions of cardiovascular system, respiratory system and digestive system;Agitation after extubation;Changes of vital signs ( oxygen saturation, mean arterial pressure, heart rate );Pain score;Subjective dyspnea degree of patients;Airway intervention;The time from admission to extubation, the time from extubation to discharge, and the total recovery time ( the time from admission to leaving the resuscitation room ) were recorded.;Lowest aaturation of oxygen;Severe hypoxemia;

Countries

China

Contacts

Public ContactJianhui Liu

Tongji Hospital of Tongji University

jianhuiliu_1246@163.com+86 21 66111140

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026